BIXT — Bioxytran Cashflow Statement
0.000.00%
Last trade - 00:00
- $22.06m
- $23.25m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -1.86 | -2.54 | -4.53 | -2.66 | -4.37 |
Amortisation | |||||
Non-Cash Items | 1.31 | 1.18 | 0.66 | 0.544 | 1.58 |
Other Non-Cash Items | |||||
Changes in Working Capital | 0.121 | 0.263 | 2.17 | 0.304 | 2 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | -0.431 | -1.1 | -1.7 | -1.81 | -0.775 |
Capital Expenditures | — | -0.01 | -0.037 | -0.032 | -0.044 |
Purchase / Acquisition of Intangibles | |||||
Cash from Investing Activities | — | -0.01 | -0.037 | -0.032 | -0.044 |
Financing Cash Flow Items | — | 0.95 | 0.6 | 0.68 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.564 | 0.981 | 1.76 | 2.06 | 0.55 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.133 | -0.128 | 0.031 | 0.223 | -0.269 |